Serum BDNF levels are associated with the risk and severity of Alzheimer’s disease dementia [146,147], whereas BDNF Val66Met polymorphisms are associated with the phenotypic variability seen in patients with frontotemporal lobar degeneration (FTLD) syndromes [148]. This evidence concerns the gene BDNF and Alzheimer disease.